FV
Flagship Ventures
Cambridge, Massachusetts, United StatesFounded 1999
Flagship Pioneering, formerly Flagship Ventures, focuses on inventing and building bioplatform companies that aim to transform human health and sustainability. Their strategy involves pioneering original science and leveraging a unique, hypothesis-driven innovation process to create and scale breakthrough ventures, often utilizing AI-enabled platforms.
75% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $98.6M (across 4 rounds with reported amounts).
Portfolio
4
Fund Size
$14B
Top Stage
Unknown
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
4 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Codiak BioSciences Inc. | Series A | $80M | Nov 2015 |
 Denali Therapeutics Inc. | Series D | $217M | May 2015 |
| Denali Therapeutics Inc. | Unknown | $88M | May 2015 |
| BBlack Duck Software | Unknown | $9.5M | Feb 2009 |
Top Co-Investors
ARCH Venture Partners3 shared
Alaska Permanent Fund3 shared
Fidelity Biosciences2 shared
General Catalyst1 shared
Fidelity Investments1 shared
Intel Capital1 shared
SAP1 shared
Red Hat1 shared
Alexandria Venture Investments1 shared
Last updated: 16 April 2026